Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sezary Syndrome 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 Hodgkin Disease 1 Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 125 Peripheral Blood Stem Cell Transplantation 84 fludarabine phosphate 81 Etoposide 73 Filgrastim 64 Mycophenolic Acid 63 Tacrolimus 57 Whole-Body Irradiation 55 Busulfan 52 Doxorubicin 50 Radiotherapy 48 Melphalan 48 Cyclosporine 47 Brentuximab Vedotin 45 Rituximab 39 Vinblastine 37 fludarabine 36 Granulocyte Colony-Stimulating Factor 36 Antilymphocyte Serum 35 Prednisone 33 Methotrexate 32 Vincristine 31 Gemcitabine 30 Dacarbazine 29 Bleomycin 29 Cytarabine 26 Carmustine 22 Bendamustine Hydrochloride 21 Sirolimus 18 Ifosfamide 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Hodgkin Disease × resminostat × Clear all

NCT01037478 2014-01-16

SAPHIRE

4SC AG

Phase 2 Completed

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡